| INTRODUCTION The
normal breast is made up of lobules and ducts (Slide 1). Both are lined by
two layers of cells: inner secretory epithelial cells and
outer myoepithelial cells (Slide
2).
Epithelial cells have columnar or cuboidal shape and
their amount of cytoplasm depends on the hormonal
influence. Under active hormonal stimulation, the cells
maintain tall shape and abundant cytoplasm. Cuboidal
configuration and decreased cytoplasm characterize
inactive hormonal influence.
- Myoepithelial cells are located beneath the
epithelial cells and have smaller, darker nuclei,
which are elongated when cut longitudinal and
triangular in cross sections. In longitudinal
sections, myoepithelial cells have fibrillar
eosinophilic cytoplasm, due to the presence of
smooth muscle contractile protein, which provides
contractility to squeeze the duct and to push the
secretory product towards the nipple.
Myoepithelial cells can be identified by
immunohistochemical stains for S-100 protein and
smooth muscle actin (Slide
3).
- I. FIBROCYSTIC CHANGE
-
- Fibrocystic "disease" or change is one
of the most common benign conditions that affects
more than 50 percent of women having palpably
irregular breasts, cyclic pain, and tenderness.
It is related to regular and, sometimes
irregular, menstrual cycles with hormonal
fluctuations. The target organ, mammary tissue,
in response to the imbalanced estrogen and
progesterone stimulation over time, undergoes a
wide variety of morphologic changes under the old
term of fibrocystic change. Essentially, at the
time of increased estrogenic stimulation
epithelial cells proliferate in the ducts (ductal
hyperplasia) and lobules (adenosis). With
decreased estrogen levels, the epithelium
involutes, the ducts become cystic, and the
lobules and stroma increase fibrous tissue
(sclerosing adenosis and stromal fibrosis,
respectively).
- Thus, fibrocystic change occurs in the
following three major elements through the
mediation of estrogen and progesterone
receptors:
- 1. ducts: ductal hyperplasia and cyst
formation
- 2. lobules: adenosis (lobular hyperplasia)
and sclerosing adenosis
- 3. stroma: fibrosis
- A lack of uniform criteria for the term of
"fibrocystic change" for many years
created controversies as to the relationship to
breast cancer. The original study by Dupont and
Page (1985) has demonstrated the importance of
precisely classifying and specifying epithelial
proliferations into those with and without
atypia. Based on the review of more than 10,500
consecutive benign breast biopsies for benign
diseases from 3,300 women who were followed for a
median period of 17 years, the relative risk of
specific changes is summarized as follows:
| Proliferative
Lesions and their Relative Risks for Developing
Invasive Breast Cancer*
|
- Nonproliferative
changes: 70% of cases
- Relative Risk =
1.0
|
- Adenosis
- Cysts and apocrine change
- Ductal ectasia
- Mild epithelial hyperplasia of usual type
|
- Proliferative
disease without atypia: 26% of cases
- Relative Risk =
1.5-2.0
|
- Hyperplasia of usual type, moderate or
florid
- Papilloma
- Sclerosing adenosis
|
- Proliferative
disease with atypia: 4% of cases
- Relative Risk =
4-5
|
- Atypical ductal hyperplasia
- Atypical lobular hyperplasia
|
| *Modified from Table 1 by DL
Page and WD Dupont: Premalignant conditions and
markers of elevated risk in the breast and their
management. Surg Clin N Amer 1990;70:831-851. |
- How to translate the relative risk
factors to prevalence rates? During
a 15-year follow-up period, 20% of women who have
atypical hyperplasia and a family history of
breast cancer developed breast cancer, as
compared to 8% for those with atypical
hyperplasia and without family history. The
comparable rates are 2% for women without
non-proliferative change and 4% with
proliferative change without atypia.
- In the subsequent studies by Dupont and Page
(1986 and 1989), the highest risk for the
development of invasive breast carcinoma occurs
during the first 10 years after biopsy and the
risk decreases thereafter. This implies that the
most critical follow-up should be the initial 10
years following diagnosis.
-
- The importance of atypical hyperplasia as a
biologic marker for increased risk of developing
invasive breast cancer has been confirmed in a
multicenter study involving more than 280,000
women (Dupont et al, 1993). For these reasons,
the morphologic criteria and definition as
proposed by Dupont and Page are adopted in this
presentation. Needless to say, these changes
should be recognized and reported in the
pathology reports.
A. Cysts
Cysts are fluid-filled spaces that originate from
the terminal ductal lobular unit or from an
obstructed ectatic duct. They are frequently multiple
and bilateral and may vary in size from microscopic
to a few centimeters. Cysts are the most common
breast masses in women aged 40 to 50 years (Bassett
et al).
The cysts are usually multiple and measure in size
from 2 mm to greater than one cm (Slides 4 and 5). They are lined
attenuated, atrophic ductal cells (Slide 6) or apocrine
metaplastic cells (Slide 7).
The apocrine cells have abundant eosinophilic,
granular cytoplasm and cytoplasmic protrusions into
the luminal border, so called apocrine snouts (Slide 8). The nuclei often
prominent nucleoli. It is common to find papillary
projections (Slide 9).
B. Epithelial Hyperplasia With
and Without Atypia
Epithelial hyperplasia is divided into ductal and
lobular types under the low power microscopic
observation. In general, lobules include acini and
terminal ductules, whereas ducts comprise of
interlobular ducts and beyond. It should be
emphasized that, due to the substantial individual
variations under the influence of hormones, the
separation between lobules and ducts is subjective
and sometimes arbitrary.
The "usual" ductal hyperplasia The
morphologic hallmarks of ductal hyperplasia is
increased cellularity and altered architectures, most
commonly with
- 1. papillary formation (Slide 10)
- 2. sieve-like, cribriform, back to back
pattern (Slide
11)
- 3. solid filling of ductal lumens (Slide 10)
These ductal hyperplasias have also been referred
to by various authors as epitheliosis and
papillomatosis. In ductal hyperplasia, both
epithelial and myoepithelial cells proliferate giving
the impression of a heterogeneous population of cells
(Slide 12). There is a
mild irregularity in nuclear size and shape.
Based on the architecture, ductal hyperplasia is
graded as mild, and moderate (or florid). In the
latter, solid pattern predominates.
In the presence of architectural and nuclear
atypicality, the ductal hyperplasia is designated as
atypical ductal or lobular hyperplasia. These
atypical hyperplasias are defined as having some but
not all the morphologic features of carcinoma in
situ.
In atypical ductal hyperplasia, the proliferating
atypical cells have enlarged, irregular,
hyperchromatic nuclei, and small nucleoli (Slides 13-14-15-16). They are mixed with
the normal secretory or myoepithelial cells without
reaching to a homogeneous population of atypical
cells expected of a ductal carcinoma in situ (Page
and Anderson).
It is common for ductal and atypical ductal
hyperplasias to undergo focal stromal fibrosis,
elastosis, and hyalinization producing stellate
shaped, indurated lesions, the so called radial scar.
This lesion will be discussed in a later section
along with papilloma.
Atypical lobular hyperplasia is characterized by
partial expansion of the lobules and the atypical
cells are loosely cohesive. Their nuclei are slightly
larger than the normal cells, slightly irregular in
shape and variable in size. The chromatin particles
are fine chromatin particles and the nucleoli are
small. In the background, myoepithelial cells,
although reduced in number, can still be identified (Slides 17 and 18) (Page and Anderson).
In lobular carcinoma in situ, the lobules are
expanded and solidly filled by atypical cells. The
myoepithelial cells are absent, except a few in the
periphery of the lobules.
C. Adenosis
Adenosis refers to a spectrum of changes within
the lobules beginning from the hyperplasia to the
subsequent fibrosis and calcifications. The term
adenosis tumor is used by some authors, when the
adenosis presents as a mass.
In the early stage of adenosis, the lobules are
enlarged with an increased number of acini (Slides 19 and 20). Later, myoepithelial
proliferation and stromal fibrosis cause distortion
of the individual acini, the so called sclerosing
adenosis (Slides 21
and 22). Within the
acini, laminated, purple, psammoma bodies often occur
(Slide 22). A
compressed, cord-like arrangement sometimes simulate
invasive carcinomas. Although the lobular borders
become irregular, the lobules remain intact (Slides 21 and 23). With further stromal
fibrosis and atrophy, the acini become few in number
and the lobules become small (Slides 23 and 24).
It is important to appreciate the lobular pattern
under low power magnification. On high power, the
preservation of the basement membrane and normal two
cell layer of the acini is indication of benignancy.
Microglandular adenosis is typically seen in
postmenopausal women. Clusters of round glandular
profiles occur in the adipose tissue (Slide 25). This feature
and a single layer of lining cells sometimes lead to
an erroneous diagnosis of tubular carcinoma (Slide 26).
D. Fibrosis (Fibrous
Mastopathy)
Fibrosis or fibrous mastopathy is an increase
of fibrous connective tissue, which is usually
hypo- to acellular. The lobules in particular are
reduced in number and in size (Slide 27). Focal
fibrosis may present as a palpable mass or as an
impalpable mammographic abnormality. A variant of
fibrosis occurs in some women with a long history
of insulin-dependent diabetes mellitus, referred
to as diabetic fibrous breast disease.
|